Logo

Bulldog Bio, Fluxion Reach Distribution Deal for Flow Cell Instruments

Jul 30, 2013 | staff reporter

NEW YORK (GenomeWeb News) – Bulldog Bio today said it will distribute Fluxion Biosciences' flow cell instruments to research laboratories in North America.

Under the terms of the announced deal, Bulldog will distribute Fluxion's BioFlux EZ and BioFlux 200 systems in the US and Canada. Financial and other terms were not disclosed.

South San Francisco, Calif.-based Fluxion provides tools for cellular analysis and in May, it and Molecular Devices reached a global distribution deal for Fluxion's IonFlux instruments and consumables.

Earlier this month, Bulldog announced an exclusive deal to sell Nippon Genetics Europe's electrophoresis and cell biology products in the US.

Filed under

distribution agreement
flow cytometry
Fluxion
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.